Post Categories
Blog post not found!
QPS COVID-19 Testing Capabilities
November 11, 2020
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…
Gene Therapy and Inherited Retinal Diseases
November 9, 2020
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…
Oligonucleotides: Innovations in Antivirals for Novel Viruses
November 2, 2020
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…
UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
October 29, 2020
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…
Animals and the COVID-19 Pandemic: Contributions and Risks
October 19, 2020
Global cases of the novel coronavirus have surpassed thirty-seven million, and the global fatality count is now more than one million. Most media and…
23andMe Data Bolsters Link Between COVID-19 and Blood Types
October 12, 2020
Did you know that a person’s blood type may be linked to the likelihood that they will catch COVID-19 and experience severe symptoms? Recently 23andMe,…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
